290 related articles for article (PubMed ID: 27815257)
1. SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage.
Bindu S; Pillai VB; Kanwal A; Samant S; Mutlu GM; Verdin E; Dulin N; Gupta MP
Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L68-L78. PubMed ID: 27815257
[TBL] [Abstract][Full Text] [Related]
2. Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice.
Pillai VB; Bindu S; Sharp W; Fang YH; Kim G; Gupta M; Samant S; Gupta MP
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H962-72. PubMed ID: 26873966
[TBL] [Abstract][Full Text] [Related]
3. Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression.
Zhang HX; Li YN; Wang XL; Ye CL; Zhu XY; Li HP; Yang T; Liu YJ
Pulm Pharmacol Ther; 2019 Aug; 57():101803. PubMed ID: 31085231
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
5. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
[TBL] [Abstract][Full Text] [Related]
6. SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis.
Jablonski RP; Kim SJ; Cheresh P; Williams DB; Morales-Nebreda L; Cheng Y; Yeldandi A; Bhorade S; Pardo A; Selman M; Ridge K; Gius D; Budinger GRS; Kamp DW
FASEB J; 2017 Jun; 31(6):2520-2532. PubMed ID: 28258190
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
Koo HY; El-Baz LM; House S; Cilvik SN; Dorry SJ; Shoukry NM; Salem ML; Hafez HS; Dulin NO; Ornitz DM; Guzy RD
J Pathol; 2018 Sep; 246(1):54-66. PubMed ID: 29873400
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
[TBL] [Abstract][Full Text] [Related]
10. Sirtuin 3 is essential for hypertension-induced cardiac fibrosis via mediating pericyte transition.
Su H; Zeng H; Liu B; Chen JX
J Cell Mol Med; 2020 Jul; 24(14):8057-8068. PubMed ID: 32463172
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP.
Han YY; Gu X; Yang CY; Ji HM; Lan YJ; Bi YQ; Si R; Qu J; Cheng MH; Gao J
J Cell Physiol; 2021 Nov; 236(11):7734-7744. PubMed ID: 34061990
[TBL] [Abstract][Full Text] [Related]
12. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
13. Classical transient receptor potential 6 (TRPC6) channels support myofibroblast differentiation and development of experimental pulmonary fibrosis.
Hofmann K; Fiedler S; Vierkotten S; Weber J; Klee S; Jia J; Zwickenpflug W; Flockerzi V; Storch U; Yildirim AÖ; Gudermann T; Königshoff M; Dietrich A
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):560-568. PubMed ID: 27932059
[TBL] [Abstract][Full Text] [Related]
14. The Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary Fibrosis.
Kim SJ; Cheresh P; Jablonski RP; Williams DB; Kamp DW
Int J Mol Sci; 2015 Sep; 16(9):21486-519. PubMed ID: 26370974
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin attenuates pulmonary fibrosis in mice and human lung fibroblasts, by the regulation of myofibroblast differentiation and apoptosis.
Yildirim M; Kayalar O; Atahan E; Oztay F
J Biochem Mol Toxicol; 2022 Jul; 36(7):e23074. PubMed ID: 35416377
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-β1/Smad2 and nuclear factor-κB signaling pathways in human fetal lung fibroblasts.
Zhang Q; Tu W; Tian K; Han L; Wang Q; Chen P; Zhou X
J Cell Biochem; 2019 Jan; 120(1):93-104. PubMed ID: 30230565
[TBL] [Abstract][Full Text] [Related]
17. 8-Oxoguanine DNA glycosylase modulates the cell transformation process in pulmonary fibrosis by inhibiting Smad2/3 and interacting with Smad7.
Wang Y; Chen T; Pan Z; Lin Z; Yang L; Zou B; Yao W; Feng D; Huangfu C; Lin C; Wu G; Ling H; Liu G
FASEB J; 2020 Oct; 34(10):13461-13473. PubMed ID: 32808374
[TBL] [Abstract][Full Text] [Related]
18. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
[TBL] [Abstract][Full Text] [Related]
19. SIRT3 Overexpression Ameliorates Asbestos-Induced Pulmonary Fibrosis, mt-DNA Damage, and Lung Fibrogenic Monocyte Recruitment.
Cheresh P; Kim SJ; Jablonski R; Watanabe S; Lu Z; Chi M; Helmin KA; Gius D; Budinger GRS; Kamp DW
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202229
[TBL] [Abstract][Full Text] [Related]
20. Qingfei xieding prescription ameliorates mitochondrial DNA-initiated inflammation in bleomycin-induced pulmonary fibrosis through activating autophagy.
Wang Y; He X; Wang H; Hu W; Sun L
J Ethnopharmacol; 2024 May; 325():117820. PubMed ID: 38286157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
